Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Scott's and 99Speedmart Join Forces to Launch Donation Campaign to Serve Underprivileged Children's Nutritional Needs
2023-10-12 18:56
Asieris Unveiled Results of Its Phase III Clinical Study for APL-1706, an Imaging Drug for Diagnosis or Surgery of Bladder Cancer, at the SIU 2023 Congress
2023-10-12 18:49
Neoss® Group receives EU Medical Device Regulation (MDR) certifications for implants and abutments
2023-10-12 18:34
So-Young Announces Board Change
2023-10-12 18:00
Prestigious World Congress of Neurology Returns In-Person to Convene World-Class Researchers in Montreal
2023-10-12 18:00
Saving on Health Insurance in Hong Kong with NowCompare.com.hk
2023-10-12 14:38
ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID TUMORS
2023-10-12 10:37
Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Management
2023-10-12 09:00
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
2023-10-12 06:00
CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites
2023-10-12 05:00
MicuRx announces poster presentation and participation in ID Week 2023 Conference
2023-10-11 23:33
SINGAPORE AND JAPAN CLINICIAN-SCIENTISTS COLLABORATE ON GROUNDBREAKING TELESURGERY TRIAL SPANNING OVER 5,000KM
2023-10-11 22:13
Kintor Pharma Announces the Approval for Phase II Clinical Trial of Hedgehog/SMO Inhibitor GT1708F for Treatment of IPF in China
2023-10-11 17:20
KHB Becomes First Chinese Company to Obtain EU Class D IVDR Certification for Its Rapid Test HIV Colloidal Gold Diagnostic Kit
2023-10-11 16:27
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
2023-10-11 14:00
EQT to acquire VetPartners, the leading provider of veterinary and animal health services in Australia and New Zealand
2023-10-11 12:21
TaiGen Enters Exclusive License Agreement with YSP
2023-10-11 11:24
GC Biopharma Shares its Successful HR System Transformation at SAP Success Connect 2023
2023-10-11 08:49
Ascletis Announces Poster Presentation of Phase II Study Topline Results of FASN Inhibitor ASC40 for Treatment of Acne at EADV Congress 2023
2023-10-11 08:10
VISTA Eye Specialist Achieves International Recognition at European Congress
2023-10-11 08:00
1
97
98
99
100
101
1510